The analysis of lacquer crack in the assessment of myopic choroidal neovascularization

Objective The aim of this study was to clarify the characteristic findings in myopic choroidal neovascularization (CNV) and the relationship with lacquer crack (LC). Methods In all, 66 consecutive myopic CNV patients treated with photodynamic therapy and/or intravitreal anti-vascular endothelial gro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Eye (London) 2011-07, Vol.25 (7), p.937-946
Hauptverfasser: Kim, Y M, Yoon, J U, Koh, H J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 946
container_issue 7
container_start_page 937
container_title Eye (London)
container_volume 25
creator Kim, Y M
Yoon, J U
Koh, H J
description Objective The aim of this study was to clarify the characteristic findings in myopic choroidal neovascularization (CNV) and the relationship with lacquer crack (LC). Methods In all, 66 consecutive myopic CNV patients treated with photodynamic therapy and/or intravitreal anti-vascular endothelial growth factor injection in one eye were reviewed. Data from fluorescein angiography (FA) and indocyanine green angiography (ICGA), obtained simultaneously using the Heidelberg retina angiograph 2 (HRA2), were analyzed. Results LCs were associated with a relatively large extent (≥3000  μ m) of peripapillary choroidal atrophy and a dark rim, the proliferation of retinal pigment epithelial cells surrounding the neovascular membrane was accompanied by a small extent. Myopic CNV usually developed in the LC area surrounded by tiny crack fragments. In all, 35 patients with LCs received FA and ICGA at least twice during follow-up. LC progression was observed in nine (25.7%) treated eyes and six (23.1%) non-CNV fellow eyes. Crack fragments progressed in three distinct forms such as elongation, branching, or bridging pattern. Newly diagnosed myopic CNV was reported in 18 treated eyes and 3 fellow eyes. Progression of LCs and development of CNV occurred simultaneously in eight eyes. By multivariate Cox's regression, a statistically significant association was observed between recurrence of myopic CNV and the absence of a dark rim on ICGA. Conclusions The HRA2 instrument affords detailed high-resolution images of FA and ICGA. Notably, recurrence of myopic CNV developed in areas surrounded by new small crack fragments and LCs are considered to be important in the development of myopic CNV.
doi_str_mv 10.1038/eye.2011.94
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3178161</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>877404414</sourcerecordid><originalsourceid>FETCH-LOGICAL-c534t-ed392498f95728e12aaa7826c880e648e3442234cf9dc158ecf5fae402a13b423</originalsourceid><addsrcrecordid>eNpt0U1P3DAQBmCrKoIt5dQ7jXrpAbL4M7EvSBUqUAmpF1pxswbvhDUk8WInSNtfj6OlS1v15MM8ej32S8gHRueMCn2Ca5xzytjcyDdkxmRdlUoq-ZbMqFG05Jzf7JF3Kd1Tmoc13SV7nCleG6Vn5Of1EgvooV0nn4rQFC24xxFj4SK4h8L3xTCBlDClDvthIt06rLwr3DLE4BfQFj2GJ0hubCH6XzD40L8nOw20CQ9ezn3y4_zr9dllefX94tvZl6vSKSGHEhfCcGl0Y1TNNTIOALXmldOaYiU1Cik5F9I1ZuGY0uga1QBKyoGJW8nFPjnd5K7G2w4XLm8YobWr6DuIaxvA278nvV_au_BkBas1q1gO-PwSEEN-dxps55PDtoX8qDFZXdeSSslklp_-kfdhjPnnJqRpJZRRGR1tkIshpYjNdhVG7dSWzW3ZqS1rpsjDP7ff2t_1ZHC8ASmP-juMr3f-P-_jhvcwjBG3edlMJItntd-rJA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>878063595</pqid></control><display><type>article</type><title>The analysis of lacquer crack in the assessment of myopic choroidal neovascularization</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Kim, Y M ; Yoon, J U ; Koh, H J</creator><creatorcontrib>Kim, Y M ; Yoon, J U ; Koh, H J</creatorcontrib><description>Objective The aim of this study was to clarify the characteristic findings in myopic choroidal neovascularization (CNV) and the relationship with lacquer crack (LC). Methods In all, 66 consecutive myopic CNV patients treated with photodynamic therapy and/or intravitreal anti-vascular endothelial growth factor injection in one eye were reviewed. Data from fluorescein angiography (FA) and indocyanine green angiography (ICGA), obtained simultaneously using the Heidelberg retina angiograph 2 (HRA2), were analyzed. Results LCs were associated with a relatively large extent (≥3000  μ m) of peripapillary choroidal atrophy and a dark rim, the proliferation of retinal pigment epithelial cells surrounding the neovascular membrane was accompanied by a small extent. Myopic CNV usually developed in the LC area surrounded by tiny crack fragments. In all, 35 patients with LCs received FA and ICGA at least twice during follow-up. LC progression was observed in nine (25.7%) treated eyes and six (23.1%) non-CNV fellow eyes. Crack fragments progressed in three distinct forms such as elongation, branching, or bridging pattern. Newly diagnosed myopic CNV was reported in 18 treated eyes and 3 fellow eyes. Progression of LCs and development of CNV occurred simultaneously in eight eyes. By multivariate Cox's regression, a statistically significant association was observed between recurrence of myopic CNV and the absence of a dark rim on ICGA. Conclusions The HRA2 instrument affords detailed high-resolution images of FA and ICGA. Notably, recurrence of myopic CNV developed in areas surrounded by new small crack fragments and LCs are considered to be important in the development of myopic CNV.</description><identifier>ISSN: 0950-222X</identifier><identifier>EISSN: 1476-5454</identifier><identifier>DOI: 10.1038/eye.2011.94</identifier><identifier>PMID: 21527958</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/420 ; 692/699 ; 692/700/1421/1770 ; 692/700/1750 ; Adult ; Antibodies, Monoclonal - administration &amp; dosage ; Antibodies, Monoclonal, Humanized ; Bevacizumab ; Choroidal Neovascularization - drug therapy ; Choroidal Neovascularization - pathology ; Clinical Study ; Coloring Agents ; Female ; Fluorescein Angiography - methods ; Humans ; Immunologic Factors - administration &amp; dosage ; Indocyanine Green ; Laboratory Medicine ; Male ; Medicine ; Medicine &amp; Public Health ; Microscopy, Confocal - methods ; Middle Aged ; Myopia, Degenerative - drug therapy ; Myopia, Degenerative - pathology ; Ophthalmology ; Pharmaceutical Sciences/Technology ; Ranibizumab ; Retrospective Studies ; Surgery ; Surgical Oncology</subject><ispartof>Eye (London), 2011-07, Vol.25 (7), p.937-946</ispartof><rights>Royal College of Ophthalmologists 2011</rights><rights>Copyright Nature Publishing Group Jul 2011</rights><rights>Copyright © 2011 Royal College of Ophthalmologists 2011 Royal College of Ophthalmologists</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c534t-ed392498f95728e12aaa7826c880e648e3442234cf9dc158ecf5fae402a13b423</citedby><cites>FETCH-LOGICAL-c534t-ed392498f95728e12aaa7826c880e648e3442234cf9dc158ecf5fae402a13b423</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3178161/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3178161/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21527958$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kim, Y M</creatorcontrib><creatorcontrib>Yoon, J U</creatorcontrib><creatorcontrib>Koh, H J</creatorcontrib><title>The analysis of lacquer crack in the assessment of myopic choroidal neovascularization</title><title>Eye (London)</title><addtitle>Eye</addtitle><addtitle>Eye (Lond)</addtitle><description>Objective The aim of this study was to clarify the characteristic findings in myopic choroidal neovascularization (CNV) and the relationship with lacquer crack (LC). Methods In all, 66 consecutive myopic CNV patients treated with photodynamic therapy and/or intravitreal anti-vascular endothelial growth factor injection in one eye were reviewed. Data from fluorescein angiography (FA) and indocyanine green angiography (ICGA), obtained simultaneously using the Heidelberg retina angiograph 2 (HRA2), were analyzed. Results LCs were associated with a relatively large extent (≥3000  μ m) of peripapillary choroidal atrophy and a dark rim, the proliferation of retinal pigment epithelial cells surrounding the neovascular membrane was accompanied by a small extent. Myopic CNV usually developed in the LC area surrounded by tiny crack fragments. In all, 35 patients with LCs received FA and ICGA at least twice during follow-up. LC progression was observed in nine (25.7%) treated eyes and six (23.1%) non-CNV fellow eyes. Crack fragments progressed in three distinct forms such as elongation, branching, or bridging pattern. Newly diagnosed myopic CNV was reported in 18 treated eyes and 3 fellow eyes. Progression of LCs and development of CNV occurred simultaneously in eight eyes. By multivariate Cox's regression, a statistically significant association was observed between recurrence of myopic CNV and the absence of a dark rim on ICGA. Conclusions The HRA2 instrument affords detailed high-resolution images of FA and ICGA. Notably, recurrence of myopic CNV developed in areas surrounded by new small crack fragments and LCs are considered to be important in the development of myopic CNV.</description><subject>692/420</subject><subject>692/699</subject><subject>692/700/1421/1770</subject><subject>692/700/1750</subject><subject>Adult</subject><subject>Antibodies, Monoclonal - administration &amp; dosage</subject><subject>Antibodies, Monoclonal, Humanized</subject><subject>Bevacizumab</subject><subject>Choroidal Neovascularization - drug therapy</subject><subject>Choroidal Neovascularization - pathology</subject><subject>Clinical Study</subject><subject>Coloring Agents</subject><subject>Female</subject><subject>Fluorescein Angiography - methods</subject><subject>Humans</subject><subject>Immunologic Factors - administration &amp; dosage</subject><subject>Indocyanine Green</subject><subject>Laboratory Medicine</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Microscopy, Confocal - methods</subject><subject>Middle Aged</subject><subject>Myopia, Degenerative - drug therapy</subject><subject>Myopia, Degenerative - pathology</subject><subject>Ophthalmology</subject><subject>Pharmaceutical Sciences/Technology</subject><subject>Ranibizumab</subject><subject>Retrospective Studies</subject><subject>Surgery</subject><subject>Surgical Oncology</subject><issn>0950-222X</issn><issn>1476-5454</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNpt0U1P3DAQBmCrKoIt5dQ7jXrpAbL4M7EvSBUqUAmpF1pxswbvhDUk8WInSNtfj6OlS1v15MM8ej32S8gHRueMCn2Ca5xzytjcyDdkxmRdlUoq-ZbMqFG05Jzf7JF3Kd1Tmoc13SV7nCleG6Vn5Of1EgvooV0nn4rQFC24xxFj4SK4h8L3xTCBlDClDvthIt06rLwr3DLE4BfQFj2GJ0hubCH6XzD40L8nOw20CQ9ezn3y4_zr9dllefX94tvZl6vSKSGHEhfCcGl0Y1TNNTIOALXmldOaYiU1Cik5F9I1ZuGY0uga1QBKyoGJW8nFPjnd5K7G2w4XLm8YobWr6DuIaxvA278nvV_au_BkBas1q1gO-PwSEEN-dxps55PDtoX8qDFZXdeSSslklp_-kfdhjPnnJqRpJZRRGR1tkIshpYjNdhVG7dSWzW3ZqS1rpsjDP7ff2t_1ZHC8ASmP-juMr3f-P-_jhvcwjBG3edlMJItntd-rJA</recordid><startdate>20110701</startdate><enddate>20110701</enddate><creator>Kim, Y M</creator><creator>Yoon, J U</creator><creator>Koh, H J</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20110701</creationdate><title>The analysis of lacquer crack in the assessment of myopic choroidal neovascularization</title><author>Kim, Y M ; Yoon, J U ; Koh, H J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c534t-ed392498f95728e12aaa7826c880e648e3442234cf9dc158ecf5fae402a13b423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>692/420</topic><topic>692/699</topic><topic>692/700/1421/1770</topic><topic>692/700/1750</topic><topic>Adult</topic><topic>Antibodies, Monoclonal - administration &amp; dosage</topic><topic>Antibodies, Monoclonal, Humanized</topic><topic>Bevacizumab</topic><topic>Choroidal Neovascularization - drug therapy</topic><topic>Choroidal Neovascularization - pathology</topic><topic>Clinical Study</topic><topic>Coloring Agents</topic><topic>Female</topic><topic>Fluorescein Angiography - methods</topic><topic>Humans</topic><topic>Immunologic Factors - administration &amp; dosage</topic><topic>Indocyanine Green</topic><topic>Laboratory Medicine</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Microscopy, Confocal - methods</topic><topic>Middle Aged</topic><topic>Myopia, Degenerative - drug therapy</topic><topic>Myopia, Degenerative - pathology</topic><topic>Ophthalmology</topic><topic>Pharmaceutical Sciences/Technology</topic><topic>Ranibizumab</topic><topic>Retrospective Studies</topic><topic>Surgery</topic><topic>Surgical Oncology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kim, Y M</creatorcontrib><creatorcontrib>Yoon, J U</creatorcontrib><creatorcontrib>Koh, H J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Eye (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kim, Y M</au><au>Yoon, J U</au><au>Koh, H J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The analysis of lacquer crack in the assessment of myopic choroidal neovascularization</atitle><jtitle>Eye (London)</jtitle><stitle>Eye</stitle><addtitle>Eye (Lond)</addtitle><date>2011-07-01</date><risdate>2011</risdate><volume>25</volume><issue>7</issue><spage>937</spage><epage>946</epage><pages>937-946</pages><issn>0950-222X</issn><eissn>1476-5454</eissn><abstract>Objective The aim of this study was to clarify the characteristic findings in myopic choroidal neovascularization (CNV) and the relationship with lacquer crack (LC). Methods In all, 66 consecutive myopic CNV patients treated with photodynamic therapy and/or intravitreal anti-vascular endothelial growth factor injection in one eye were reviewed. Data from fluorescein angiography (FA) and indocyanine green angiography (ICGA), obtained simultaneously using the Heidelberg retina angiograph 2 (HRA2), were analyzed. Results LCs were associated with a relatively large extent (≥3000  μ m) of peripapillary choroidal atrophy and a dark rim, the proliferation of retinal pigment epithelial cells surrounding the neovascular membrane was accompanied by a small extent. Myopic CNV usually developed in the LC area surrounded by tiny crack fragments. In all, 35 patients with LCs received FA and ICGA at least twice during follow-up. LC progression was observed in nine (25.7%) treated eyes and six (23.1%) non-CNV fellow eyes. Crack fragments progressed in three distinct forms such as elongation, branching, or bridging pattern. Newly diagnosed myopic CNV was reported in 18 treated eyes and 3 fellow eyes. Progression of LCs and development of CNV occurred simultaneously in eight eyes. By multivariate Cox's regression, a statistically significant association was observed between recurrence of myopic CNV and the absence of a dark rim on ICGA. Conclusions The HRA2 instrument affords detailed high-resolution images of FA and ICGA. Notably, recurrence of myopic CNV developed in areas surrounded by new small crack fragments and LCs are considered to be important in the development of myopic CNV.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>21527958</pmid><doi>10.1038/eye.2011.94</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0950-222X
ispartof Eye (London), 2011-07, Vol.25 (7), p.937-946
issn 0950-222X
1476-5454
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3178161
source MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection
subjects 692/420
692/699
692/700/1421/1770
692/700/1750
Adult
Antibodies, Monoclonal - administration & dosage
Antibodies, Monoclonal, Humanized
Bevacizumab
Choroidal Neovascularization - drug therapy
Choroidal Neovascularization - pathology
Clinical Study
Coloring Agents
Female
Fluorescein Angiography - methods
Humans
Immunologic Factors - administration & dosage
Indocyanine Green
Laboratory Medicine
Male
Medicine
Medicine & Public Health
Microscopy, Confocal - methods
Middle Aged
Myopia, Degenerative - drug therapy
Myopia, Degenerative - pathology
Ophthalmology
Pharmaceutical Sciences/Technology
Ranibizumab
Retrospective Studies
Surgery
Surgical Oncology
title The analysis of lacquer crack in the assessment of myopic choroidal neovascularization
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T05%3A57%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20analysis%20of%20lacquer%20crack%20in%20the%20assessment%20of%20myopic%20choroidal%20neovascularization&rft.jtitle=Eye%20(London)&rft.au=Kim,%20Y%20M&rft.date=2011-07-01&rft.volume=25&rft.issue=7&rft.spage=937&rft.epage=946&rft.pages=937-946&rft.issn=0950-222X&rft.eissn=1476-5454&rft_id=info:doi/10.1038/eye.2011.94&rft_dat=%3Cproquest_pubme%3E877404414%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=878063595&rft_id=info:pmid/21527958&rfr_iscdi=true